Patents by Inventor William E. Tente

William E. Tente has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • SYSTEMS, DEVICES AND METHODS FOR ENGINEERED TISSUE CONSTRUCT TRANSPORT AND CONTAINMENT
    Publication number: 20230026520
    Abstract: In some embodiments, an engineered tissue construct (ETC) transport and containment method is provided and includes storing a bioreactor and an ETC contained therein within a transport package via an opening in the package, and sealing the opening. Some embodiments are also directed at methods for sterilizing packaging and bioreactors contained therein.
    Type: Application
    Filed: December 11, 2020
    Publication date: January 26, 2023
    Inventors: Robert SCHUTTE, Dustin CASHMAN, Heather L. PRICHARD, Josh MCCALL, William E. TENTE, Shannon L.M. DAHL, Laura E. NIKLASON
  • TISSUE-ENGINEERED CONSTRUCTS
    Publication number: 20210246419
    Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.
    Type: Application
    Filed: January 27, 2021
    Publication date: August 12, 2021
    Applicant: Humacyte, Inc.
    Inventors: Shannon L.M. DAHL, Laura E. NIKLASON, Justin T. STRADER, William E. TENTE, Joseph J. LUNDQUIST, Juliana Blum, Heather L. Prichard
  • Tissue-engineered constructs
    Patent number: 10947498
    Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.
    Type: Grant
    Filed: June 13, 2018
    Date of Patent: March 16, 2021
    Assignee: humacyte, inc.
    Inventors: Shannon L. M. Dahl, Laura E. Niklason, Justin T. Strader, William E. Tente, Joseph J. Lundquist
  • Tissue-engineered constructs
    Patent number: 10934522
    Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.
    Type: Grant
    Filed: May 8, 2018
    Date of Patent: March 2, 2021
    Assignee: Humacyte, Inc.
    Inventors: Shannon L. M. Dahl, Laura E. Niklason, Justin T. Strader, William E. Tente, Joseph J. Lundquist
  • Tissue-engineered constructs
    Patent number: 10619132
    Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.
    Type: Grant
    Filed: May 15, 2017
    Date of Patent: April 14, 2020
    Assignee: Humacyte, Inc.
    Inventors: Shannon L. M. Dahl, Laura E. Niklason, Justin T. Strader, William E. Tente, Joseph J. Lundquist
  • TISSUE-ENGINEERED CONSTRUCTS
    Publication number: 20180291333
    Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.
    Type: Application
    Filed: June 13, 2018
    Publication date: October 11, 2018
    Applicant: Humacyte, Inc.
    Inventors: Shannon L.M. DAHL, Laura E. NIKLASON, Justin T. STRADER, William E. TENTE, Joseph J. LUNDQUIST
  • TISSUE-ENGINEERED CONSTRUCTS
    Publication number: 20180251727
    Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.
    Type: Application
    Filed: May 8, 2018
    Publication date: September 6, 2018
    Applicant: Humacyte, Inc.
    Inventors: Shannon L.M. DAHL, Laura E. NIKLASON, Justin T. STRADER, William E. TENTE, Joseph J. LUNDQUIST
  • TISSUE-ENGINEERED CONSTRUCTS
    Publication number: 20170306292
    Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.
    Type: Application
    Filed: May 15, 2017
    Publication date: October 26, 2017
    Inventors: Shannon L.M. DAHL, Laura E. Niklason, Justin T. Strader, William E. Tente, Joseph J. Lundquist
  • Tubular tissue-engineered constructs
    Patent number: 9657265
    Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.
    Type: Grant
    Filed: September 24, 2014
    Date of Patent: May 23, 2017
    Assignee: Humacyte, Inc.
    Inventors: Shannon L. M. Dahl, Laura E. Niklason, Juliana Blum, Justin T. Strader, William E. Tente, Heather L. Prichard, Joseph J. Lundquist
  • TISSUE-ENGINEERED CONSTRUCTS
    Publication number: 20170135805
    Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.
    Type: Application
    Filed: January 31, 2017
    Publication date: May 18, 2017
    Inventors: Shannon L.M. DAHL, Laura E. NIKLASON, Juliana BLUM, Justin T. STRADER, William E. TENTE, Heather L. PRICHARD, Joseph J. LUNDQUIST
  • Tissue-engineered constructs
    Patent number: 9650603
    Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.
    Type: Grant
    Filed: September 24, 2014
    Date of Patent: May 16, 2017
    Assignee: Humacyte, Inc.
    Inventors: Shannon L. M. Dahl, Laura E. Niklason, Justin T. Strader, William E. Tente, Joseph J. Lundquist
  • Tissue-engineered constructs
    Patent number: 9556414
    Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.
    Type: Grant
    Filed: January 6, 2012
    Date of Patent: January 31, 2017
    Assignee: HUMACYTE
    Inventors: Shannon L. M. Dahl, Laura E. Niklason, Juliana Blum, Justin T. Strader, William E. Tente, Heather L. Prichard, Joseph J. Lundquist
  • Tissue and organ graft bioreactor and method of operation
    Patent number: 9127242
    Abstract: A single-use, single or multiple tissue, organ, and graft bioreactor and environmental control system is designed to replicate the necessary conditions for growth of tissues, organs, or grafts, while addressing problems in scaling up the tissue growth; adaptation to a single-use or disposable format; and operation as a stand-alone unit that provides full environmental control of cell culture conditions.
    Type: Grant
    Filed: April 5, 2010
    Date of Patent: September 8, 2015
    Inventors: Patrick M. Guertin, Parrish M. Galliher, Michael Fisher, Joseph D. Crowell, Colin R. Tuohey, Laura A. Niklason, William E. Tente, Shannon M. Dahl, Juliana Blum, Justin Strader
  • TISSUE-ENGINEERED CONSTRUCTS
    Publication number: 20150031131
    Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.
    Type: Application
    Filed: September 24, 2014
    Publication date: January 29, 2015
    Inventors: Shannon L.M. Dahl, Laura E. Niklason, Justin T. Strader, William E. Tente, Joseph J. Lundquist
  • TUBULAR TISSUE-ENGINEERED CONSTRUCTS
    Publication number: 20150012083
    Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.
    Type: Application
    Filed: September 24, 2014
    Publication date: January 8, 2015
    Inventors: Shannon L.M. Dahl, Laura E. Niklason, Juliana Blum, Justin T. Strader, William E. Tente, Heather L. Prichard, Joseph J. Lundquist
  • TISSUED-ENGINEERED CONSTRUCTS
    Publication number: 20130345824
    Abstract: The present invention provides constructs including a tubular biodegradable polyglycolic acid scaffold, wherein the scaffold may be coated with extracellular matrix proteins and substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, a peripheral artery bypass conduit, or a urinary conduit. The present invention also provides methods of producing such constructs.
    Type: Application
    Filed: January 6, 2012
    Publication date: December 26, 2013
    Applicant: HUMACYTE
    Inventors: Shannon L.M. Dahl, Laura E. Niklason, Juliana Blum, Justin T. Strader, William E. Tente, Heather L. Prichard, Joseph Lundquist
  • Tissue-Engineered Constructs
    Publication number: 20130013083
    Abstract: Constructs including a tubular biodegradable polyglycolic acid scaffold may be coated with extracellular matrix proteins and are substantially acellular. The constructs can be utilized as an arteriovenous graft, a coronary graft, an arterial graft, a venous graft, a duct graft, a skin graft, or a urinary graft or conduit.
    Type: Application
    Filed: July 5, 2012
    Publication date: January 10, 2013
    Applicant: HUMACYTE
    Inventors: Juliana L. BLUM, Shannon L.M. DAHL, Laura E. NIKLASON, Justin T. STRADER, William E. TENTE, Heather L. PRITCHARD, Joseph J. LUNDQUIST
  • TISSUE AND ORGAN GRAFT BIOREACTOR AND METHOD OF OPERATION
    Publication number: 20120028234
    Abstract: A single-use, single or multiple tissue, organ, and graft bioreactor and environmental control system is designed to replicate the necessary conditions for growth of tissues, organs, or grafts, while addressing problems in scaling up the tissue growth; adaptation to a single-use or disposable format; and operation as a stand-alone unit that provides full environmental control of cell culture conditions.
    Type: Application
    Filed: April 5, 2010
    Publication date: February 2, 2012
    Inventors: Patrick M. Guertin, Parrish M. Galliher, Michael Fisher, Joseph D. Crowell, Colin R. Tuohey, Laura A. Niklason, William E. Tente, Shannon M. Dahl, Juliana Blum, Justin Strader